Prasuray 5 Tablet contains Prasugrel 5 mg, a thienopyridine class anti-platelet agent used to prevent platelet aggregation and reduce the risk of thrombotic events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).
Belonging to the cardiology and anti-platelet segment, Prasugrel is widely prescribed by cardiologists for secondary prevention of heart attacks and stent thrombosis. Its potent platelet inhibition ensures effective management of high-risk cardiovascular patients.
The tablet works by irreversibly inhibiting the P2Y12 receptor on platelets, reducing clot formation and improving blood flow in coronary arteries. This mechanism helps prevent recurrent cardiovascular events and supports long-term cardiac health.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Prasuray 5 Tablet offers a profitable B2B opportunity, catering to hospitals, cardiology clinics, and specialty pharmacies across India.
Common side effects may include bleeding, bruising, or mild gastrointestinal discomfort. Rare but serious side effects include severe bleeding, hemorrhagic stroke, or allergic reactions. Seek immediate medical attention if you experience unusual or prolonged bleeding, black stools, or severe dizziness.
Prasuray 5 Tablet is indicated for the prevention of thrombotic events, such as heart attack or stroke, in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). It helps reduce the risk of clot-related complications in high-risk cardiac patients.
Take Prasuray 5 Tablet exactly as prescribed and do not stop therapy without consulting your doctor. Inform your healthcare provider if you have a history of bleeding disorders, recent surgery, or are taking other blood-thinning medications. Regular monitoring may be required during treatment.
Store Prasuray 5 Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.